PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,888,170 | -31.4% | 860,423 | -12.9% | 0.00% | -100.0% |
Q2 2023 | $12,947,646 | +22.3% | 987,616 | +4.3% | 0.00% | 0.0% |
Q1 2023 | $10,587,203 | +0.1% | 946,977 | -24.5% | 0.00% | – |
Q4 2022 | $10,577,796 | -24.7% | 1,254,780 | +48.9% | 0.00% | -100.0% |
Q3 2022 | $14,042,000 | +16.4% | 842,851 | +2.9% | 0.00% | 0.0% |
Q2 2022 | $12,063,000 | -39.8% | 819,484 | +1.4% | 0.00% | 0.0% |
Q1 2022 | $20,041,000 | -13.4% | 807,790 | +11.9% | 0.00% | 0.0% |
Q4 2021 | $23,152,000 | -10.1% | 721,935 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $25,759,000 | -1.2% | 715,919 | +21.1% | 0.00% | 0.0% |
Q2 2021 | $26,075,000 | +68.4% | 590,994 | +74.6% | 0.00% | 0.0% |
Q1 2021 | $15,487,000 | +26.5% | 338,581 | +90.9% | 0.00% | 0.0% |
Q4 2020 | $12,244,000 | – | 177,405 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |